"experiment","well","celltype","analyte","nocodazole_dose_ng_ml","treatment","dose_uM","time_in_noc_min","aim","cell_id","data_table"
2011,"C03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"RNAi – Mad2, Noc, Control","2011_C03","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C03.csv"
2011,"C03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"RNAi – Mad2, Noc, Control","2011_C03 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C03 (2).csv"
2011,"C03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"RNAi – Mad2, Noc, Control","2011_C03 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C03 (3).csv"
2011,"C03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"RNAi – Mad2, Noc, Control","2011_C03 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C03 (4).csv"
2011,"C03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"RNAi – Mad2, Noc, Control","2011_C03 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C03 (5).csv"
2011,"C03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"RNAi – Mad2, Noc, Control","2011_C03 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C03 (6).csv"
2011,"C10","HeLa","Securin-eGFP",0,"RNAi-Mad2",0.0,0,"RNAi – Mad2, Noc, Control","2011_C10","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C10.csv"
2011,"C10","HeLa","Securin-eGFP",0,"RNAi-Mad2",0.0,0,"RNAi – Mad2, Noc, Control","2011_C10 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C10 (2).csv"
2011,"C10","HeLa","Securin-eGFP",0,"RNAi-Mad2",0.0,0,"RNAi – Mad2, Noc, Control","2011_C10 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C10 (3).csv"
2011,"C10","HeLa","Securin-eGFP",0,"RNAi-Mad2",0.0,0,"RNAi – Mad2, Noc, Control","2011_C10 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C10 (4).csv"
2011,"C10","HeLa","Securin-eGFP",0,"RNAi-Mad2",0.0,0,"RNAi – Mad2, Noc, Control","2011_C10 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C10 (5).csv"
2011,"C10","HeLa","Securin-eGFP",0,"RNAi-Mad2",0.0,0,"RNAi – Mad2, Noc, Control","2011_C10 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/C10 (6).csv"
2011,"D05","HeLa","Securin-eGFP",100,"noc_only",0.0,0,"Noc added before imaging only cells analyzed that entered mitosis in presence of Nocodazole","2011_D05","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/D05.csv"
2011,"D05","HeLa","Securin-eGFP",100,"noc_only",0.0,0,"Noc added before imaging only cells analyzed that entered mitosis in presence of Nocodazole","2011_D05 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/D05 (2).csv"
2011,"D05","HeLa","Securin-eGFP",100,"noc_only",0.0,0,"Noc added before imaging only cells analyzed that entered mitosis in presence of Nocodazole","2011_D05 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/D05 (3).csv"
2011,"D05","HeLa","Securin-eGFP",100,"noc_only",0.0,0,"Noc added before imaging only cells analyzed that entered mitosis in presence of Nocodazole","2011_D05 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2011/D05 (4).csv"
2016,"B03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"control","2016_B03","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/B03.csv"
2016,"B03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"control","2016_B03 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/B03 (2).csv"
2016,"B03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"control","2016_B03 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/B03 (4).csv"
2016,"B03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"control","2016_B03 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/B03 (5).csv"
2016,"B03","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"control","2016_B03 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/B03 (6).csv"
2016,"C04","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_C04","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/C04.csv"
2016,"C04","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_C04 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/C04 (2).csv"
2016,"C04","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_C04 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/C04 (3).csv"
2016,"C04","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_C04 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/C04 (4).csv"
2016,"C04","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_C04 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/C04 (5).csv"
2016,"C04","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_C04 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/C04 (6).csv"
2016,"D02","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D02","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D02.csv"
2016,"D02","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D02 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D02 (2).csv"
2016,"D02","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D02 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D02 (3).csv"
2016,"D02","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D02 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D02 (4).csv"
2016,"D02","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D02 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D02 (5).csv"
2016,"D02","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D02 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D02 (6).csv"
2016,"D02","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D02 (7)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D02 (7).csv"
2016,"D05","HeLa","Securin-eGFP",0,"RNAi-Allstar",0.0,0,"??? were missing","2016_D05","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2016/D05.csv"
2640,"B2","HeLa","Securin-eGFP",100,"RNAi-Allstar + Flavopiridol",20.0,234,"acute SAC abrogation in different transfection controls","2640_B2S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B2S1.csv"
2640,"B2","HeLa","Securin-eGFP",100,"RNAi-Allstar + Flavopiridol",20.0,234,"acute SAC abrogation in different transfection controls","2640_B2S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B2S1 (2).csv"
2640,"B2","HeLa","Securin-eGFP",100,"RNAi-Allstar + Flavopiridol",20.0,234,"acute SAC abrogation in different transfection controls","2640_B2S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B2S1 (3).csv"
2640,"B2","HeLa","Securin-eGFP",100,"RNAi-Allstar + Flavopiridol",20.0,234,"acute SAC abrogation in different transfection controls","2640_B2S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B2S1 (4).csv"
2640,"B2","HeLa","Securin-eGFP",100,"RNAi-Allstar + Flavopiridol",20.0,234,"acute SAC abrogation in different transfection controls","2640_B2S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B2S2.csv"
2640,"B3","HeLa","Securin-eGFP",100,"RNAi-Allstar-washout + Flavopiridol",20.0,138,"acute SAC abrogation in different transfection controls","2640_B3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B3S1.csv"
2640,"B3","HeLa","Securin-eGFP",100,"RNAi-Allstar-washout + Flavopiridol",20.0,138,"acute SAC abrogation in different transfection controls","2640_B3S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B3S1 (2).csv"
2640,"B3","HeLa","Securin-eGFP",100,"RNAi-Allstar-washout + Flavopiridol",20.0,138,"acute SAC abrogation in different transfection controls","2640_B3S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B3S2.csv"
2640,"B3","HeLa","Securin-eGFP",100,"RNAi-Allstar-washout + Flavopiridol",20.0,138,"acute SAC abrogation in different transfection controls","2640_B3S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B3S2 (2).csv"
2640,"B3","HeLa","Securin-eGFP",100,"RNAi-Allstar-washout + Flavopiridol",20.0,138,"acute SAC abrogation in different transfection controls","2640_B3S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B3S2 (3).csv"
2640,"B4","HeLa","Securin-eGFP",100,"RNAi-LaminA/C + Flavopiridol",20.0,280,"acute SAC abrogation in different transfection controls","2640_B4S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B4S3.csv"
2640,"B4","HeLa","Securin-eGFP",100,"RNAi-LaminA/C + Flavopiridol",20.0,280,"acute SAC abrogation in different transfection controls","2640_B4S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B4S3 (2).csv"
2640,"B4","HeLa","Securin-eGFP",100,"RNAi-LaminA/C + Flavopiridol",20.0,280,"acute SAC abrogation in different transfection controls","2640_B4S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B4S3 (3).csv"
2640,"B4","HeLa","Securin-eGFP",100,"RNAi-LaminA/C + Flavopiridol",20.0,280,"acute SAC abrogation in different transfection controls","2640_B4S3 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B4S3 (4).csv"
2640,"B4","HeLa","Securin-eGFP",100,"RNAi-LaminA/C + Flavopiridol",20.0,280,"acute SAC abrogation in different transfection controls","2640_B4S3 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B4S3 (5).csv"
2640,"B6","HeLa","Securin-eGFP",100,"RNAi-transfection + Flavopiridol",20.0,76,"acute SAC abrogation in different transfection controls","2640_B6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B6S1.csv"
2640,"B6","HeLa","Securin-eGFP",100,"RNAi-transfection + Flavopiridol",20.0,76,"acute SAC abrogation in different transfection controls","2640_B6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B6S1 (2).csv"
2640,"B6","HeLa","Securin-eGFP",100,"RNAi-transfection + Flavopiridol",20.0,76,"acute SAC abrogation in different transfection controls","2640_B6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B6S2.csv"
2640,"B6","HeLa","Securin-eGFP",100,"RNAi-transfection + Flavopiridol",20.0,76,"acute SAC abrogation in different transfection controls","2640_B6S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B6S2 (2).csv"
2640,"B6","HeLa","Securin-eGFP",100,"RNAi-transfection + Flavopiridol",20.0,76,"acute SAC abrogation in different transfection controls","2640_B6S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/B6S2 (3).csv"
2640,"C5","HeLa","Securin-eGFP",100,"untreated + Flavopiridol",20.0,172,"acute SAC abrogation in different transfection controls","2640_C5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/C5S1.csv"
2640,"C5","HeLa","Securin-eGFP",100,"untreated + Flavopiridol",20.0,172,"acute SAC abrogation in different transfection controls","2640_C5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/C5S1 (2).csv"
2640,"C5","HeLa","Securin-eGFP",100,"untreated + Flavopiridol",20.0,172,"acute SAC abrogation in different transfection controls","2640_C5S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/C5S1 (3).csv"
2640,"C5","HeLa","Securin-eGFP",100,"untreated + Flavopiridol",20.0,172,"acute SAC abrogation in different transfection controls","2640_C5S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/C5S1 (4).csv"
2640,"C5","HeLa","Securin-eGFP",100,"untreated + Flavopiridol",20.0,172,"acute SAC abrogation in different transfection controls","2640_C5S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2640/C5S1 (5).csv"
2672,"B3","HeLa","Securin-eGFP",100,"Flavopiridol",20.0,319,"test acute SAC abrogation with increasing CDK inhibition","2672_B3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/B3S1.csv"
2672,"B3","HeLa","Securin-eGFP",100,"Flavopiridol",20.0,319,"test acute SAC abrogation with increasing CDK inhibition","2672_B3S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/B3S1-2.csv"
2672,"B3","HeLa","Securin-eGFP",100,"Flavopiridol",20.0,319,"test acute SAC abrogation with increasing CDK inhibition","2672_B3S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/B3S1-3.csv"
2672,"C3","HeLa","Securin-eGFP",100,"Flavopiridol",20.0,85,"test acute SAC abrogation with increasing CDK inhibition","2672_C3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/C3S1.csv"
2672,"C3","HeLa","Securin-eGFP",100,"Flavopiridol",20.0,85,"test acute SAC abrogation with increasing CDK inhibition","2672_C3S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/C3S1-2.csv"
2672,"C3","HeLa","Securin-eGFP",100,"Flavopiridol",20.0,85,"test acute SAC abrogation with increasing CDK inhibition","2672_C3S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/C3S1-3.csv"
2672,"E2","HeLa","Securin-eGFP",100,"Flavopiridol",10.0,131,"test acute SAC abrogation with increasing CDK inhibition","2672_E2S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/E2S1.csv"
2672,"E2","HeLa","Securin-eGFP",100,"Flavopiridol",10.0,131,"test acute SAC abrogation with increasing CDK inhibition","2672_E2S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/E2S1-2.csv"
2672,"E2","HeLa","Securin-eGFP",100,"Flavopiridol",10.0,131,"test acute SAC abrogation with increasing CDK inhibition","2672_E2S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/E2S1-3.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S1.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S1-2.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S1-3.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S1-4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S1-4.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S1-5","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S1-5.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S1-6","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S1-6.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S2.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S2-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S2-2.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S2-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S2-3.csv"
2672,"F2","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,177,"test acute SAC abrogation with increasing CDK inhibition","2672_F2S2-4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F2S2-4.csv"
2672,"F3","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,222,"test acute SAC abrogation with increasing CDK inhibition","2672_F3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F3S1.csv"
2672,"F3","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,222,"test acute SAC abrogation with increasing CDK inhibition","2672_F3S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F3S1 (2).csv"
2672,"F3","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,222,"test acute SAC abrogation with increasing CDK inhibition","2672_F3S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F3S1 (3).csv"
2672,"F3","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,222,"test acute SAC abrogation with increasing CDK inhibition","2672_F3S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2672/F3S1 (4).csv"
2692,"C5","HeLa","Securin-eGFP",100,"RO-3306",13.3,80,"test acute SAC abrogation with increasing CDK1 inhibition","2692_C5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/C5S1.csv"
2692,"C5","HeLa","Securin-eGFP",100,"RO-3306",13.3,80,"test acute SAC abrogation with increasing CDK1 inhibition","2692_C5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/C5S1 (2).csv"
2692,"C5","HeLa","Securin-eGFP",100,"RO-3306",13.3,80,"test acute SAC abrogation with increasing CDK1 inhibition","2692_C5S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/C5S1 (3).csv"
2692,"C6","HeLa","Securin-eGFP",100,"noc_only",0.0,504,"test acute SAC abrogation with increasing CDK1 inhibition","2692_C6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/C6S1.csv"
2692,"C6","HeLa","Securin-eGFP",100,"noc_only",0.0,504,"test acute SAC abrogation with increasing CDK1 inhibition","2692_C6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/C6S1 (2).csv"
2692,"C6","HeLa","Securin-eGFP",100,"noc_only",0.0,504,"test acute SAC abrogation with increasing CDK1 inhibition","2692_C6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/C6S1 (3).csv"
2692,"C6","HeLa","Securin-eGFP",100,"noc_only",0.0,504,"test acute SAC abrogation with increasing CDK1 inhibition","2692_C6S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/C6S1 (4).csv"
2692,"D5","HeLa","Securin-eGFP",100,"RO-3306",6.6,120,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D5S1.csv"
2692,"D5","HeLa","Securin-eGFP",100,"RO-3306",6.6,120,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D5S1 (2).csv"
2692,"D5","HeLa","Securin-eGFP",100,"RO-3306",6.6,120,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D5S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D5S3.csv"
2692,"D5","HeLa","Securin-eGFP",100,"RO-3306",6.6,120,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D5S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D5S3 (2).csv"
2692,"D6","HeLa","Securin-eGFP",100,"RO-3306",0.8,418,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D6S1.csv"
2692,"D6","HeLa","Securin-eGFP",100,"RO-3306",0.8,418,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D6S1 (2).csv"
2692,"D6","HeLa","Securin-eGFP",100,"RO-3306",0.8,418,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D6S1 (3).csv"
2692,"D6","HeLa","Securin-eGFP",100,"RO-3306",0.8,418,"test acute SAC abrogation with increasing CDK1 inhibition","2692_D6S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/D6S1 (4).csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S1.csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S1 (2).csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S1 (3).csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S2.csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S2 (2).csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S2 (3).csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S3.csv"
2692,"F5","HeLa","Securin-eGFP",100,"RO-3306",3.3,166,"test acute SAC abrogation with increasing CDK1 inhibition","2692_F5S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/F5S3 (2).csv"
2692,"G6","HeLa","Securin-eGFP",100,"RO-3306",1.7,254,"test acute SAC abrogation with increasing CDK1 inhibition","2692_G6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/G6S1.csv"
2692,"G6","HeLa","Securin-eGFP",100,"RO-3306",1.7,254,"test acute SAC abrogation with increasing CDK1 inhibition","2692_G6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/G6S1 (2).csv"
2692,"G6","HeLa","Securin-eGFP",100,"RO-3306",1.7,254,"test acute SAC abrogation with increasing CDK1 inhibition","2692_G6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/G6S1 (3).csv"
2692,"G6","HeLa","Securin-eGFP",100,"RO-3306",1.7,254,"test acute SAC abrogation with increasing CDK1 inhibition","2692_G6S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/G6S1 (4).csv"
2692,"G6","HeLa","Securin-eGFP",100,"RO-3306",1.7,254,"test acute SAC abrogation with increasing CDK1 inhibition","2692_G6S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2692/G6S1 (5).csv"
2702,"C5","HeLa","Securin-eGFP",100,"Reversine",0.125,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_C5S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/C5S2.csv"
2702,"C5","HeLa","Securin-eGFP",100,"Reversine",0.125,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_C5S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/C5S2 (2).csv"
2702,"C5","HeLa","Securin-eGFP",100,"Reversine",0.125,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_C5S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/C5S2 (3).csv"
2702,"C5","HeLa","Securin-eGFP",100,"Reversine",0.125,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_C5S2 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/C5S2 (4).csv"
2702,"C5","HeLa","Securin-eGFP",100,"Reversine",0.125,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_C5S2 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/C5S2 (5).csv"
2702,"D5","HeLa","Securin-eGFP",100,"Reversine",0.5,53,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D5S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D5S2.csv"
2702,"D5","HeLa","Securin-eGFP",100,"Reversine",0.5,53,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D5S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D5S2 (2).csv"
2702,"D5","HeLa","Securin-eGFP",100,"Reversine",0.5,53,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D5S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D5S2 (3).csv"
2702,"D5","HeLa","Securin-eGFP",100,"Reversine",0.5,53,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D5S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D5S4.csv"
2702,"D5","HeLa","Securin-eGFP",100,"Reversine",0.5,53,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D5S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D5S4 (2).csv"
2702,"D5","HeLa","Securin-eGFP",100,"Reversine",0.5,53,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D5S4 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D5S4 (3).csv"
2702,"D6","HeLa","Securin-eGFP",100,"noc_only",0.0,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D6S1.csv"
2702,"D6","HeLa","Securin-eGFP",100,"noc_only",0.0,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D6S1 (2).csv"
2702,"D6","HeLa","Securin-eGFP",100,"noc_only",0.0,233,"test acute SAC abrogation with increasing Mps1 inhibition","2702_D6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/D6S1 (3).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S1.csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S1 (2).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S2.csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S2 (2).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S2 (3).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S3.csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S3 (2).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S3 (3).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S3 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S3 (4).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S3 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S3 (5).csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S4.csv"
2702,"E5","HeLa","Securin-eGFP",100,"Reversine",0.25,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E5S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E5S4 (2).csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S1.csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S1 (2).csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S1 (3).csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S1 (4).csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S1 (5).csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S1 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S1 (6).csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S1 (7)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S1 (7).csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S2.csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S3.csv"
2702,"E6","HeLa","Securin-eGFP",100,"Reversine",1.0,103,"test acute SAC abrogation with increasing Mps1 inhibition","2702_E6S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2702/E6S3 (2).csv"
2703,"B2","HeLa","Securin-eGFP",100,"noc_only",0.0,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_B2S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/B2S1.csv"
2703,"B2","HeLa","Securin-eGFP",100,"noc_only",0.0,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_B2S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/B2S1-2.csv"
2703,"B2","HeLa","Securin-eGFP",100,"noc_only",0.0,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_B2S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/B2S4.csv"
2703,"B2","HeLa","Securin-eGFP",100,"noc_only",0.0,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_B2S4-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/B2S4-2.csv"
2703,"B2","HeLa","Securin-eGFP",100,"noc_only",0.0,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_B2S4-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/B2S4-3.csv"
2703,"C3","HeLa","Securin-eGFP",100,"RO-3306",1.7,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_C3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/C3S1.csv"
2703,"C3","HeLa","Securin-eGFP",100,"RO-3306",1.7,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_C3S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/C3S1-2.csv"
2703,"C3","HeLa","Securin-eGFP",100,"RO-3306",1.7,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_C3S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/C3S1-3.csv"
2703,"C3","HeLa","Securin-eGFP",100,"RO-3306",1.7,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_C3S1-4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/C3S1-4.csv"
2703,"C3","HeLa","Securin-eGFP",100,"RO-3306",1.7,1094,"test acute SAC abrogation with increasing CDK inhibition","2703_C3S1-5","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/C3S1-5.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S2.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S2-1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S2-1.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S3.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S3-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S3-2.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S3-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S3-3.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S3-4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S3-4.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S3-5","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S3-5.csv"
2703,"F2","HeLa","Securin-eGFP",100,"RO-3306",3.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_F2S3-6","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/F2S3-6.csv"
2703,"G2","HeLa","Securin-eGFP",100,"RO-3306",6.6,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G2S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G2S1.csv"
2703,"G2","HeLa","Securin-eGFP",100,"RO-3306",6.6,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G2S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G2S1-2.csv"
2703,"G2","HeLa","Securin-eGFP",100,"RO-3306",6.6,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G2S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G2S1-3.csv"
2703,"G2","HeLa","Securin-eGFP",100,"RO-3306",6.6,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G2S1-4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G2S1-4.csv"
2703,"G2","HeLa","Securin-eGFP",100,"RO-3306",6.6,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G2S1-5","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G2S1-5.csv"
2703,"G3","HeLa","Securin-eGFP",100,"RO-3306",13.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G3S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G3S2.csv"
2703,"G3","HeLa","Securin-eGFP",100,"RO-3306",13.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G3S2-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G3S2-2.csv"
2703,"G3","HeLa","Securin-eGFP",100,"RO-3306",13.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G3S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G3S4.csv"
2703,"G3","HeLa","Securin-eGFP",100,"RO-3306",13.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G3S4-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G3S4-2.csv"
2703,"G3","HeLa","Securin-eGFP",100,"RO-3306",13.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G3S4-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G3S4-3.csv"
2703,"G3","HeLa","Securin-eGFP",100,"RO-3306",13.3,126,"test acute SAC abrogation with increasing CDK inhibition","2703_G3S4-4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2703/G3S4-4.csv"
2717,"B3","HeLa","H2B-mCherry",0,"untreated",0.0,0,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B3S1.csv"
2717,"B3","HeLa","H2B-mCherry",0,"untreated",0.0,0,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B3S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B3S1-2.csv"
2717,"B3","HeLa","H2B-mCherry",0,"untreated",0.0,0,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B3S1-2-ana","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B3S1-2-ana.csv"
2717,"B3","HeLa","H2B-mCherry",0,"untreated",0.0,0,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B3S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B3S1-3.csv"
2717,"B3","HeLa","H2B-mCherry",0,"untreated",0.0,0,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B3S1-3-ana","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B3S1-3-ana.csv"
2717,"B3","HeLa","H2B-mCherry",0,"untreated",0.0,0,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B3S1-ana","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B3S1-ana.csv"
2717,"B6","HeLa","H2B-mCherry",100,"RO-3306",5.0,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B6S3.csv"
2717,"B6","HeLa","H2B-mCherry",100,"RO-3306",5.0,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B6S3_2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B6S3_2.csv"
2717,"B6","HeLa","H2B-mCherry",100,"RO-3306",5.0,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B6S3_2small","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B6S3_2small.csv"
2717,"B6","HeLa","H2B-mCherry",100,"RO-3306",5.0,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_B6S3_small","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/B6S3_small.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-2.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-2-small","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-2-small.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-2decond","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-2decond.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-3.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-3-decond","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-3-decond.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-3small","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-3small.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-decon","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-decon.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S1-small","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S1-small.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S2.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S2-2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S2-2.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S2-2decon","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S2-2decon.csv"
2717,"C6","HeLa","H2B-mCherry",100,"RO-3306",2.5,369,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2717_C6S2decon","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2717/C6S2decon.csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1.csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1 (2).csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1 (3).csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1 (4).csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1 (5).csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1 (6).csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1 (7)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1 (7).csv"
2738,"B11","RPE1","CyclinB-venus",100,"Reversine",1.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_B11S1 (8)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/B11S1 (8).csv"
2738,"C11","RPE1","CyclinB-venus",100,"RO-3306",20.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_C11S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/C11S1.csv"
2738,"C11","RPE1","CyclinB-venus",100,"RO-3306",20.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_C11S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/C11S1 (2).csv"
2738,"C11","RPE1","CyclinB-venus",100,"RO-3306",20.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_C11S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/C11S1 (3).csv"
2738,"C11","RPE1","CyclinB-venus",100,"RO-3306",20.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_C11S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/C11S1 (4).csv"
2738,"D11","RPE1","CyclinB-venus",100,"RO-3306",10.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_D11S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/D11S1.csv"
2738,"D11","RPE1","CyclinB-venus",100,"RO-3306",10.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_D11S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/D11S1 (2).csv"
2738,"D11","RPE1","CyclinB-venus",100,"RO-3306",10.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_D11S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/D11S1 (3).csv"
2738,"D11","RPE1","CyclinB-venus",100,"RO-3306",10.0,135,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_D11S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/D11S1 (4).csv"
2738,"E11","RPE1","CyclinB-venus",100,"noc_only",0.0,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_E11S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/E11S3.csv"
2738,"E11","RPE1","CyclinB-venus",100,"noc_only",0.0,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_E11S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/E11S3 (2).csv"
2738,"E11","RPE1","CyclinB-venus",100,"noc_only",0.0,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_E11S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/E11S3 (3).csv"
2738,"E11","RPE1","CyclinB-venus",100,"noc_only",0.0,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_E11S3 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/E11S3 (4).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2.csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2 (2).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2 (3).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2 (4).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2 (5).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2 (6).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2 (7)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2 (7).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S2 (8)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S2 (8).csv"
2738,"F11","RPE1","CyclinB-venus",100,"Reversine",0.25,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_F11S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/F11S3.csv"
2738,"G11","RPE1","CyclinB-venus",100,"RO-3306",2.5,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_G11S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/G11S1.csv"
2738,"G11","RPE1","CyclinB-venus",100,"RO-3306",2.5,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_G11S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/G11S1 (2).csv"
2738,"G11","RPE1","CyclinB-venus",100,"RO-3306",2.5,255,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2738_G11S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2738/G11S1 (3).csv"
2754,"B3","RPE1","CyclinB-venus",100,"Flavopiridol",20.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_B3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/B3S1.csv"
2754,"B3","RPE1","CyclinB-venus",100,"Flavopiridol",20.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_B3S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/B3S1 (2).csv"
2754,"B3","RPE1","CyclinB-venus",100,"Flavopiridol",20.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_B3S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/B3S2.csv"
2754,"B3","RPE1","CyclinB-venus",100,"Flavopiridol",20.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_B3S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/B3S2 (2).csv"
2754,"B3","RPE1","CyclinB-venus",100,"Flavopiridol",20.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_B3S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/B3S2 (3).csv"
2754,"C4","RPE1","CyclinB-venus",100,"Reversine",1.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_C4S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/C4S1.csv"
2754,"C4","RPE1","CyclinB-venus",100,"Reversine",1.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_C4S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/C4S1 (2).csv"
2754,"C4","RPE1","CyclinB-venus",100,"Reversine",1.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_C4S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/C4S1 (3).csv"
2754,"C4","RPE1","CyclinB-venus",100,"Reversine",1.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_C4S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/C4S2.csv"
2754,"C4","RPE1","CyclinB-venus",100,"Reversine",1.0,163,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_C4S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/C4S2 (2).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S1.csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S1 (2).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S1 (3).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S1 (4).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S2.csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S2 (2).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S2 (3).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4.csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (10)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (10).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (2).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (3).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (4).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (5).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (6).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (7)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (7).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (8)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (8).csv"
2754,"D3","RPE1","CyclinB-venus",100,"Reversine",0.25,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_D3S4 (9)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/D3S4 (9).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S1.csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S1 (2).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S1 (3).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S1 (4).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S1 (5).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S2.csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S2 (2).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S3.csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S3 (2).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S3 (3).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S3 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S3 (4).csv"
2754,"E3","RPE1","CyclinB-venus",100,"Reversine",0.12,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E3S3 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E3S3 (5).csv"
2754,"E4","RPE1","CyclinB-venus",100,"Flavopiridol",2.5,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E4S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E4S1.csv"
2754,"E4","RPE1","CyclinB-venus",100,"Flavopiridol",2.5,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E4S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E4S1 (2).csv"
2754,"E4","RPE1","CyclinB-venus",100,"Flavopiridol",2.5,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E4S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E4S1 (3).csv"
2754,"E4","RPE1","CyclinB-venus",100,"Flavopiridol",2.5,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E4S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E4S2.csv"
2754,"E4","RPE1","CyclinB-venus",100,"Flavopiridol",2.5,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E4S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E4S2 (2).csv"
2754,"E4","RPE1","CyclinB-venus",100,"Flavopiridol",2.5,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E4S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E4S2 (3).csv"
2754,"E4","RPE1","CyclinB-venus",100,"Flavopiridol",2.5,317,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E4S2 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E4S2 (4).csv"
2754,"E5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E5S1.csv"
2754,"E5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E5S1 (2).csv"
2754,"E5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E5S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E5S1 (3).csv"
2754,"E5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E5S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E5S2.csv"
2754,"E5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2754_E5S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2754/E5S2 (2).csv"
2755,"B3","HeLa","H2B-mCherry",100,"Reversine",1.0,221,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B3S1.csv"
2755,"B3","HeLa","H2B-mCherry",100,"Reversine",1.0,221,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B3S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B3S2.csv"
2755,"B4","HeLa","H2B-mCherry",100,"Reversine",1.0,269,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B4S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B4S2.csv"
2755,"B5","HeLa","H2B-mCherry",100,"Reversine",1.0,333,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B5S1.csv"
2755,"B5","HeLa","H2B-mCherry",100,"Reversine",1.0,333,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B5S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B5S2.csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S1.csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S1 (2).csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S1 (3).csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S2.csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S3.csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S3 (2).csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S4.csv"
2755,"B6","HeLa","H2B-mCherry",100,"Reversine",0.5,387,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_B6S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/B6S4 (2).csv"
2755,"C3","HeLa","H2B-mCherry",100,"Reversine",1.0,221,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_C3S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/C3S1.csv"
2755,"C3","HeLa","H2B-mCherry",100,"Reversine",1.0,221,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_C3S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/C3S1 (2).csv"
2755,"C3","HeLa","H2B-mCherry",100,"Reversine",1.0,221,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_C3S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/C3S1 (3).csv"
2755,"C4","HeLa","H2B-mCherry",100,"Reversine",1.0,269,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_C4S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/C4S3.csv"
2755,"C4","HeLa","H2B-mCherry",100,"Reversine",1.0,269,"measure effect of cell rounding/flattening in cells (transfection with soluble GFP)","2755_C4S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2755/C4S4.csv"
2792,"C7","RPE1","CyclinB-venus",100,"Reversine",0.063,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C7S1.csv"
2792,"C7","RPE1","CyclinB-venus",100,"Reversine",0.063,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C7S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C7S2.csv"
2792,"C8","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C8S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C8S1.csv"
2792,"C8","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C8S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C8S1 (2).csv"
2792,"C8","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C8S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C8S1 (3).csv"
2792,"C8","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C8S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C8S1 (4).csv"
2792,"C8","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C8S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C8S1 (5).csv"
2792,"C8","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_C8S1c","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/C8S1c.csv"
2792,"D7","RPE1","CyclinB-venus",100,"Reversine",0.032,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_D7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/D7S1.csv"
2792,"E7","RPE1","CyclinB-venus",100,"Flavopiridol",1.25,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_E7S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/E7S2.csv"
2792,"E7","RPE1","CyclinB-venus",100,"Flavopiridol",1.25,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_E7S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/E7S2 (2).csv"
2792,"E7","RPE1","CyclinB-venus",100,"Flavopiridol",1.25,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_E7S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/E7S2 (3).csv"
2792,"E7","RPE1","CyclinB-venus",100,"Flavopiridol",1.25,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_E7S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/E7S3.csv"
2792,"E7","RPE1","CyclinB-venus",100,"Flavopiridol",1.25,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_E7S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/E7S3 (2).csv"
2792,"E7","RPE1","CyclinB-venus",100,"Flavopiridol",1.25,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_E7S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/E7S3 (3).csv"
2792,"E7","RPE1","CyclinB-venus",100,"Flavopiridol",1.25,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_E7S3 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/E7S3 (4).csv"
2792,"F7","RPE1","CyclinB-venus",100,"Flavopiridol",0.65,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_F7S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/F7S2.csv"
2792,"F7","RPE1","CyclinB-venus",100,"Flavopiridol",0.65,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_F7S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/F7S2 (2).csv"
2792,"F7","RPE1","CyclinB-venus",100,"Flavopiridol",0.65,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_F7S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/F7S3.csv"
2792,"F7","RPE1","CyclinB-venus",100,"Flavopiridol",0.65,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_F7S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/F7S3 (2).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S1.csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S1 (2).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S1 (3).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S1 (4).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S1 (5).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S2.csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S2 (2).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S2 (3).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S3.csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S3 (2).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S3 (3).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S3 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S3 (4).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S4.csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S4 (2).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S4 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S4 (3).csv"
2792,"G7","RPE1","CyclinB-venus",100,"noc_only",0.0,113,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2792_G7S4 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2792/G7S4 (4).csv"
2868,"C6","RPE1","CyclinB-venus",60,"Flavopiridol",0.63,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C6S2.csv"
2868,"C6","RPE1","CyclinB-venus",60,"Flavopiridol",0.63,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C6S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C6S2 (2).csv"
2868,"C6","RPE1","CyclinB-venus",60,"Flavopiridol",0.63,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C6S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C6S2 (3).csv"
2868,"C6","RPE1","CyclinB-venus",60,"Flavopiridol",0.63,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C6S3.csv"
2868,"C6","RPE1","CyclinB-venus",60,"Flavopiridol",0.63,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C6S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C6S3 (2).csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S1.csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S1 (2).csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S1 (3).csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S1 (4).csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S1 (5)-entry","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S1 (5)-entry.csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S2.csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S2 (2).csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S2 (3)-entry","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S2 (3)-entry.csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S2 (4)-entry","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S2 (4)-entry.csv"
2868,"C7","RPE1","CyclinB-venus",60,"RO-3306",4.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_C7S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/C7S3.csv"
2868,"D6","RPE1","CyclinB-venus",60,"Flavopiridol",1.25,261,"test acute SAC abrogation with increasing CDKinhibition","2868_D6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/D6S1.csv"
2868,"D6","RPE1","CyclinB-venus",60,"Flavopiridol",1.25,261,"test acute SAC abrogation with increasing CDKinhibition","2868_D6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/D6S1 (2).csv"
2868,"D6","RPE1","CyclinB-venus",60,"Flavopiridol",1.25,261,"test acute SAC abrogation with increasing CDKinhibition","2868_D6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/D6S1 (3).csv"
2868,"D6","RPE1","CyclinB-venus",60,"Flavopiridol",1.25,261,"test acute SAC abrogation with increasing CDKinhibition","2868_D6S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/D6S1 (4).csv"
2868,"D6","RPE1","CyclinB-venus",60,"Flavopiridol",1.25,261,"test acute SAC abrogation with increasing CDKinhibition","2868_D6S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/D6S1 (5).csv"
2868,"D6","RPE1","CyclinB-venus",60,"Flavopiridol",1.25,261,"test acute SAC abrogation with increasing CDKinhibition","2868_D6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/D6S2.csv"
2868,"E6","RPE1","CyclinB-venus",60,"noc_only",0.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E6S1.csv"
2868,"E6","RPE1","CyclinB-venus",60,"noc_only",0.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E6S1 (2).csv"
2868,"E6","RPE1","CyclinB-venus",60,"noc_only",0.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E6S1 (3).csv"
2868,"E6","RPE1","CyclinB-venus",60,"noc_only",0.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E6S2.csv"
2868,"E6","RPE1","CyclinB-venus",60,"noc_only",0.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E6S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E6S2 (2).csv"
2868,"E6","RPE1","CyclinB-venus",60,"noc_only",0.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E6S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E6S2 (3).csv"
2868,"E7","RPE1","CyclinB-venus",60,"RO-3306",8.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E7S1.csv"
2868,"E7","RPE1","CyclinB-venus",60,"RO-3306",8.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E7S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E7S1 (2).csv"
2868,"E7","RPE1","CyclinB-venus",60,"RO-3306",8.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E7S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E7S1 (3).csv"
2868,"E7","RPE1","CyclinB-venus",60,"RO-3306",8.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E7S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E7S1 (4).csv"
2868,"E7","RPE1","CyclinB-venus",60,"RO-3306",8.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E7S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E7S1 (5).csv"
2868,"E7","RPE1","CyclinB-venus",60,"RO-3306",8.0,261,"test acute SAC abrogation with increasing CDKinhibition","2868_E7S1 (6)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/E7S1 (6).csv"
2868,"F6","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDKinhibition","2868_F6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/F6S1.csv"
2868,"F6","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDKinhibition","2868_F6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/F6S1 (2).csv"
2868,"F6","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDKinhibition","2868_F6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/F6S1 (3).csv"
2868,"F6","RPE1","CyclinB-venus",0,"untreated",0.0,0,"test acute SAC abrogation with increasing CDKinhibition","2868_F6S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2868/F6S1 (4).csv"
2886,"C8","HeLa","Securin-eGFP",100,"noc_only",0.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_C8S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/C8S1.csv"
2886,"C8","HeLa","Securin-eGFP",100,"noc_only",0.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_C8S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/C8S2.csv"
2886,"C8","HeLa","Securin-eGFP",100,"noc_only",0.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_C8S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/C8S3.csv"
2886,"C8","HeLa","Securin-eGFP",100,"noc_only",0.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_C8S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/C8S4.csv"
2886,"D8","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_D8S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/D8S2.csv"
2886,"D8","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_D8S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/D8S3.csv"
2886,"D8","HeLa","Securin-eGFP",100,"Flavopiridol",5.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_D8S3(1)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/D8S3(1).csv"
2886,"D9","HeLa","Securin-eGFP",100,"RO-3306",5.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_D9S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/D9S1.csv"
2886,"D9","HeLa","Securin-eGFP",100,"RO-3306",5.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_D9S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/D9S1 (2).csv"
2886,"D9","HeLa","Securin-eGFP",100,"RO-3306",5.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_D9S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/D9S2.csv"
2886,"D9","HeLa","Securin-eGFP",100,"RO-3306",5.0,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_D9S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/D9S3.csv"
2886,"E8","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E8S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E8S1.csv"
2886,"E8","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E8S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E8S1 (2).csv"
2886,"E8","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E8S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E8S3.csv"
2886,"E8","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E8S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E8S3 (2).csv"
2886,"E8","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E8S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E8S3 (3).csv"
2886,"E8","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E8S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E8S4.csv"
2886,"E8","HeLa","Securin-eGFP",100,"Flavopiridol",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E8S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E8S4 (2).csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S2.csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S2 (2).csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S3.csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S3 (2).csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S3 (3).csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S4.csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S4 (2).csv"
2886,"E9","HeLa","Securin-eGFP",100,"RO-3306",2.5,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_E9S4 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/E9S4 (3).csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S1.csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S2.csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S2 (2).csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S2 (3).csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S2 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S2 (4).csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S3.csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S3 (2).csv"
2886,"F8","HeLa","Securin-eGFP",100,"Flavopiridol",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F8S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F8S4.csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S1.csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S1 (2).csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S2.csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S2 (2).csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S2 (3).csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S2 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S2 (4).csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S3.csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S3 (2).csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S4.csv"
2886,"F9","HeLa","Securin-eGFP",100,"RO-3306",1.25,198,"test acute SAC abrogation with increasing CDK/Mps1 inhibition","2886_F9S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2886/F9S4 (2).csv"
2919,"B6","RPE1","CyclinB-venus",100,"Flavopiridol",0.63,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B6S1.csv"
2919,"B6","RPE1","CyclinB-venus",100,"Flavopiridol",0.63,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B6S2.csv"
2919,"B6","RPE1","CyclinB-venus",100,"Flavopiridol",0.63,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B6S3.csv"
2919,"B6","RPE1","CyclinB-venus",100,"Flavopiridol",0.63,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B6S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B6S3 (2).csv"
2919,"B6","RPE1","CyclinB-venus",100,"Flavopiridol",0.63,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B6S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B6S3 (3).csv"
2919,"B7","RPE1","CyclinB-venus",100,"Flavopiridol",0.32,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B7S1.csv"
2919,"B7","RPE1","CyclinB-venus",100,"Flavopiridol",0.32,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B7S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B7S1 (2).csv"
2919,"B7","RPE1","CyclinB-venus",100,"Flavopiridol",0.32,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B7S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B7S3.csv"
2919,"B7","RPE1","CyclinB-venus",100,"Flavopiridol",0.32,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B7S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B7S3 (2).csv"
2919,"B7","RPE1","CyclinB-venus",100,"Flavopiridol",0.32,171,"test acute SAC abrogation with increasing CDKinhibition","2919_B7S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/B7S3 (3).csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S1.csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S1 (2).csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S1 (3)-entry","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S1 (3)-entry.csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S1 (4)-entry","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S1 (4)-entry.csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S1 (5)-entry","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S1 (5)-entry.csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S2.csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S2 (2).csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S2 (3).csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S3.csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S3 (2).csv"
2919,"C6","RPE1","CyclinB-venus",100,"RO-3306",3.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C6S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C6S3 (3).csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S1.csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S2.csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S2 (2).csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S2 (3).csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S2 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S2 (4).csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S3.csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S3 (2).csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S4.csv"
2919,"C7","RPE1","CyclinB-venus",100,"RO-3306",1.5,171,"test acute SAC abrogation with increasing CDKinhibition","2919_C7S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/C7S4 (2).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S1.csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S1 (2).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S1 (3).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S1 (4).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S2.csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S2 (2).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S2 (3).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S2 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S2 (5).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S3.csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S3 (2).csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S4.csv"
2919,"D6","RPE1","CyclinB-venus",100,"RO-3306",0.75,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D6S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D6S4 (2).csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S1.csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S1 (2).csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S1 (3).csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S1 (4).csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S1 (5)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S1 (5).csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S2.csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S2 (2).csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S3.csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S3 (2).csv"
2919,"D7","RPE1","CyclinB-venus",100,"noc_only",0.0,171,"test acute SAC abrogation with increasing CDKinhibition","2919_D7S3 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/2919/D7S3 (3).csv"
3081,"D5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_D5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/D5S1.csv"
3081,"D5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_D5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/D5S1 (2).csv"
3081,"D5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_D5S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/D5S1 (3).csv"
3081,"G5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G5S1_1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G5S1_1.csv"
3081,"G5","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G5S1_2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G5S1_2.csv"
3081,"G6","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G6S1_1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G6S1_1.csv"
3081,"G6","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G6S1_2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G6S1_2.csv"
3081,"G6","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G6S1_3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G6S1_3.csv"
3081,"G7","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G7S1_1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G7S1_1.csv"
3081,"G7","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G7S1_2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G7S1_2.csv"
3081,"G7","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G7S1_3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G7S1_3.csv"
3081,"G7","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G7S1_4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G7S1_4.csv"
3081,"G7","RPE1","CyclinB-venus",0,"untreated",0.0,0,"Quantify cyclin B1 degradation at the meta- to anaphase transition","3081_G7S1_5","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3081/G7S1_5.csv"
3331,"E4","RPE1","CyclinB-venus",100,"RO-3306",3.0,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; precipiates of RO continuosly \"fall down\"","3331_E4S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E4S1.csv"
3331,"E4","RPE1","CyclinB-venus",100,"RO-3306",3.0,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; precipiates of RO continuosly \"fall down\"","3331_E4S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E4S2.csv"
3331,"E4","RPE1","CyclinB-venus",100,"RO-3306",3.0,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; precipiates of RO continuosly \"fall down\"","3331_E4S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E4S2 (2).csv"
3331,"E4","RPE1","CyclinB-venus",100,"RO-3306",3.0,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; precipiates of RO continuosly \"fall down\"","3331_E4S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E4S4.csv"
3331,"E5","RPE1","CyclinB-venus",100,"RO-3306",1.5,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; no precipitates of RO seen; only very few dead cells","3331_E5S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E5S1.csv"
3331,"E5","RPE1","CyclinB-venus",100,"RO-3306",1.5,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; no precipitates of RO seen; only very few dead cells","3331_E5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E5S1 (2).csv"
3331,"E5","RPE1","CyclinB-venus",100,"RO-3306",1.5,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; no precipitates of RO seen; only very few dead cells","3331_E5S1 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E5S1 (3).csv"
3331,"E5","RPE1","CyclinB-venus",100,"RO-3306",1.5,0,"chromatin clearly decondenses after RO addition; cells enter mitosis in presence of RO; no precipitates of RO seen; only very few dead cells","3331_E5S1 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E5S1 (4).csv"
3331,"E6","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,"chromatin often decondenses after RO addition; cells enter mitosis in presence of RO; few dead cells; cells are not arrested very long!! -> even lower concentrations of RO?","3331_E6S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E6S1.csv"
3331,"E6","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,"chromatin often decondenses after RO addition; cells enter mitosis in presence of RO; few dead cells; cells are not arrested very long!! -> even lower concentrations of RO?","3331_E6S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E6S2.csv"
3331,"E6","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,"chromatin often decondenses after RO addition; cells enter mitosis in presence of RO; few dead cells; cells are not arrested very long!! -> even lower concentrations of RO?","3331_E6S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E6S3.csv"
3331,"E6","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,"chromatin often decondenses after RO addition; cells enter mitosis in presence of RO; few dead cells; cells are not arrested very long!! -> even lower concentrations of RO?","3331_E6S4x","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E6S4x.csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S1.csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S1x","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S1x.csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S2 (2).csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S2!","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S2!.csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S2x","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S2x.csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S3.csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S3 (2).csv"
3331,"E8","RPE1","CyclinB-venus",100,"RO-3306",0.75,0,NA,"3331_E8S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/E8S4.csv"
3331,"F4","RPE1","CyclinB-venus",100,"noc_only",0.0,0,"Many cells remain arrested with bright chromatin, many die (not all that appear to die stain with TopRo3!)","3331_F4S1","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F4S1.csv"
3331,"F4","RPE1","CyclinB-venus",100,"noc_only",0.0,0,"Many cells remain arrested with bright chromatin, many die (not all that appear to die stain with TopRo3!)","3331_F4S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F4S1 (2).csv"
3331,"F4","RPE1","CyclinB-venus",100,"noc_only",0.0,0,"Many cells remain arrested with bright chromatin, many die (not all that appear to die stain with TopRo3!)","3331_F4S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F4S2.csv"
3331,"F4","RPE1","CyclinB-venus",100,"noc_only",0.0,0,"Many cells remain arrested with bright chromatin, many die (not all that appear to die stain with TopRo3!)","3331_F4S3","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F4S3.csv"
3331,"F4","RPE1","CyclinB-venus",100,"noc_only",0.0,0,"Many cells remain arrested with bright chromatin, many die (not all that appear to die stain with TopRo3!)","3331_F4S3 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F4S3 (2).csv"
3331,"F4","RPE1","CyclinB-venus",100,"noc_only",0.0,0,"Many cells remain arrested with bright chromatin, many die (not all that appear to die stain with TopRo3!)","3331_F4S4","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F4S4.csv"
3331,"F4","RPE1","CyclinB-venus",100,"noc_only",0.0,0,"Many cells remain arrested with bright chromatin, many die (not all that appear to die stain with TopRo3!)","3331_F4S4 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F4S4 (2).csv"
3331,"F5","RPE1","CyclinB-venus",50,"noc_only",0.0,0,"Many cells slipp normaly out of mitosis; no alignment visisble! But also many cells  die… acceleration happens at higher cyclinB1 levels!","3331_F5S1 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F5S1 (2).csv"
3331,"F5","RPE1","CyclinB-venus",50,"noc_only",0.0,0,"Many cells slipp normaly out of mitosis; no alignment visisble! But also many cells  die… acceleration happens at higher cyclinB1 levels!","3331_F5S1-dies","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F5S1-dies.csv"
3331,"F5","RPE1","CyclinB-venus",50,"noc_only",0.0,0,"Many cells slipp normaly out of mitosis; no alignment visisble! But also many cells  die… acceleration happens at higher cyclinB1 levels!","3331_F5S2","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F5S2.csv"
3331,"F5","RPE1","CyclinB-venus",50,"noc_only",0.0,0,"Many cells slipp normaly out of mitosis; no alignment visisble! But also many cells  die… acceleration happens at higher cyclinB1 levels!","3331_F5S2 (2)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F5S2 (2).csv"
3331,"F5","RPE1","CyclinB-venus",50,"noc_only",0.0,0,"Many cells slipp normaly out of mitosis; no alignment visisble! But also many cells  die… acceleration happens at higher cyclinB1 levels!","3331_F5S2 (3)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F5S2 (3).csv"
3331,"F5","RPE1","CyclinB-venus",50,"noc_only",0.0,0,"Many cells slipp normaly out of mitosis; no alignment visisble! But also many cells  die… acceleration happens at higher cyclinB1 levels!","3331_F5S2 (4)","/home/luki/Documents/Code/Coding/amalieModelling_Project/Data/SAC_Project_2015-11-01/DataTables/extracted/3331/F5S2 (4).csv"
